Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
2020 · Scientific Reports · 43 citations
https://doi.org/10.1038/s41598-020-67697-w
H
Hun Ho Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
989
Citations
17
h-index
30
i10-index
Hun Ho Park is an academic researcher from Yonsei University. The author has contributed to research in topics: Meningioma and schwannoma management & Head and Neck Surgical Oncology & Glioma Diagnosis and Treatment. The author has an h-index of 17, co-authored 60 publications.
ORCID: 0000-0002-2526-9693Papers by this author
worksApparent diffusion coefficient as a prognostic factor in clival chordoma
2021 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-020-79894-8
Synergistic combination of perphenazine and temozolomide suppresses patient-derived glioblastoma tumorspheres
2024 · Neuro-Oncology · 8 citations
https://doi.org/10.1093/neuonc/noae211
Impact of treatment response to neoadjuvant chemotherapy on brain metastasis patterns and breast cancer prognosis
2025 · The Breast · 0 citations
https://doi.org/10.1016/j.breast.2025.104650
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat